Company Overview of AnaptysBio, Inc.
AnaptysBio, Inc., an antibody development company, engages in the discovery and development of therapeutic antibodies for inflammation and immuno-oncology. It provides ANB019, an anti-interleukin-36 receptor antibody; and ANB020, a pro-inflammatory cytokine involved in activation of allergy, asthma, and other Th2-type disorders. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was founded in 2005 and is based in San Diego, California.
10421 Pacific Center Court
San Diego, CA 92121
Founded in 2005
Key Executives for AnaptysBio, Inc.
AnaptysBio, Inc. Key Developments
Similar Private Companies By Industry
|Ives Formulation Company, Inc.||United States|
|Daiichi Sankyo, Inc.||United States|
|SFBC New Drug Services, Inc.||United States|
|Pharmachem Laboratories, Inc.||United States|
|Theranutrients, LLC||United States|
Recent Private Companies Transactions
July 13, 2015
To contact AnaptysBio, Inc., please visit www.anaptysbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.